CellBion Co., Ltd. (KOSDAQ:308430)
South Korea
· Delayed Price · Currency is KRW 28,000
+1,800 (6.87%)
At close: Mar 6, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 343.88 billion as of March 9, 2026. Its market cap has increased by 66.86% in one year.
Market Cap
343.88B
Enterprise Value
322.77B
Revenue
2.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
28,000.00
Market Cap Chart
Since October 16, 2024, CellBion's market cap has increased from 263.06B to 343.88B, an increase of 30.72%. That is a compound annual growth rate of 21.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 359.28B | 18.64% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DAE HWA Pharmaceutical | 250.31B |
| HEM Pharma | 535.01B |
| ImmuneOncia Therapeutics | 569.59B |
| NOVAREX | 225.53B |
| Vivozon Pharmaceutical | 196.71B |
| Organoidsciences | 187.36B |
| Samyang Biopharm | 689.31B |
| OPTUS Pharmaceutical | 186.35B |